SteelPeak Wealth’s 10x Genomics TXG Stock Holding History

SteelPeak Wealth’s Portfolio TXG Stock Details TXG Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2026 Q2	$309K	Buy	+8,050	New	+$211K	0.01%	516
2025 Q2	–	Sell	-37,068	Closed	-$324K	–	660
2025 Q1	$324K	Buy	+37,068	New	+$467K	0.01%	403
2024 Q3	–	Sell	-21,247	Closed	-$413K	–	608
2024 Q2	$413K	Buy	+21,247	New	+$556K	0.02%	338
2022 Q2	–	Sell	-8,809	Closed	-$671K	–	479
2022 Q1	$671K	Buy	+8,809	New	+$771K	0.04%	238

Other funds holding TXG

SAM

Simplify Asset Management Las Vegas, Nevada $7.19B AUM 6.88% 1-Year Est. Return

Wealth Enhancement Advisory Services Plymouth, Minnesota $59.8B AUM 29.42% 1-Year Est. Return

MCP

Mirador Capital Partners Pleasanton, California $817M AUM 42.46% 1-Year Est. Return

AWA

Aaron Wealth Advisors Chicago, Illinois $1.97B AUM 36.91% 1-Year Est. Return

Handelsbanken Fonder Stockholm, Sweden $35.1B AUM 47.76% 1-Year Est. Return

MFG

Merit Financial Group Alpharetta, Georgia $16.4B AUM 25.17% 1-Year Est. Return

EWM

Empirical Wealth Management Seattle, Washington $6.85B AUM 30.02% 1-Year Est. Return

VCM

Versant Capital Management Phoenix, Arizona $1.12B AUM 34.21% 1-Year Est. Return

YIH

Y-Intercept (HK) Hong Kong $5.05B AUM 17.89% 1-Year Est. Return

Ballentine Partners Waltham, Massachusetts $8.18B AUM 27.59% 1-Year Est. Return

SteelPeak Wealth's TXG Position: Q2 2026 in Review

SteelPeak Wealth opened a new position in 10x Genomics (TXG) in Q2 2026: 8,050 shares worth $309K. The stake represents 0.01% of the portfolio and ranks #516 among its holdings. This is a return to the name: SteelPeak Wealth previously reported a position in TXG as recently as Q1 2025.

SteelPeak Wealth first reported a position in TXG in Q1 2022 and has held it in 4 quarters since. The position peaked at $671K in Q1 2022. 30 funds tracked by Wall St. Rank hold TXG as of Q2 2026.

SteelPeak Wealth held 8,050 shares of 10x Genomics worth $309K as of Q2 2026.
10x Genomics was a new SteelPeak Wealth position in Q2 2026.
10x Genomics made up 0.01% of SteelPeak Wealth's portfolio in Q2 2026, its #516 holding.
SteelPeak Wealth first reported a position in 10x Genomics in Q1 2022 and has held it in 4 quarters since.
SteelPeak Wealth's 10x Genomics position peaked at $671K in Q1 2022.
30 funds tracked by Wall St. Rank held 10x Genomics as of Q2 2026.

Based on SteelPeak Wealth's 13F filing for Q2 2026, filed 13 Jul 2026.